Epigenomics AG

Here is the public summary page for Epigenomics AG. Please login to see the complete information for Epigenomics AG including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Epigenomics AG stacks up relative to its peers.

Darwin Score	+7
Ticker	ECX
Latest Price	0.73 EUR as of close on 23-Feb-2023
3 Month price range	0.32 to 1.68 EUR
Market Capitalisation	6.18Mn EUR
Country	Germany
Region	Europe
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Biotechnology
Sub-Industry	Biotechnology
Description	Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. See More ...
Company URL	https://www.epigenomics.com

See Darwins Full Analysis for Epigenomics AG

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Epigenomics AG. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+6
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	0
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	+1